KSA Listed Healthcare Market: 10 Key News Developments in August 2026

1. Bupa Arabia Reports Continued Profit Growth

Bupa Arabia (Tadawul: 8210) reported its first-half 2026
financial results during August. The company continued to benefit from
strong demand for private medical insurance, with second-quarter
profitability remaining positive.

The results reinforce the importance of health insurance as a major
component of Saudi Arabia’s expanding private healthcare ecosystem.

Market significance: Continued growth in medical
insurance supports healthcare utilization and creates a positive
environment for both insurers and healthcare providers.

2. Mouwasat Delivers Strong H1 Performance

Mouwasat Medical Services (Tadawul: 4002) reported
first-half 2026 net profit of approximately
SAR 412.4 million. Second-quarter profit reached
approximately SAR 211.4 million.

The company’s performance reflects continued demand for private
healthcare services and the contribution of its expanding hospital
network, including its Yanbu operations.

Market significance: Mouwasat remains one of the
stronger operating performers among Saudi-listed hospital operators,
demonstrating the potential for healthcare capacity expansion to
translate into earnings growth.

3. Al Hammadi Shows Improved Second-Quarter Profitability

Al Hammadi Holding (Tadawul: 4007) reported
second-quarter 2026 net profit of approximately
SAR 71.9 million, representing an increase of around
16% compared with the same period of 2025.

Although the cumulative first-half result remained under pressure, the
stronger second-quarter performance points to improving operating
momentum.

Market significance: The results highlight the
importance of quarterly earnings momentum when assessing listed
healthcare operators.

4. Dallah Healthcare Maintains Revenue Growth Despite Profit Pressure

Dallah Healthcare (Tadawul: 4004) reported second-quarter
revenue of approximately SAR 1.1 billion.

Reported profitability was affected by non-recurring and financing-related
factors, while underlying operating activity remained relatively
resilient, supported by increased patient activity and continued
healthcare-service expansion.

Dallah also announced a shareholder vote concerning a proposed
20% capital increase through bonus shares, scheduled for
30 August 2026.

Market significance: Dallah illustrates how strong
healthcare demand can coexist with short-term profitability pressure
caused by financing and expansion requirements.

5. SMC Healthcare Reports Strong Earnings Momentum

Specialized Medical Company (SMC Healthcare, Tadawul: 4019)
reported a strong first-half 2026 performance.

H1 net profit reached approximately SAR 77.7 million,
representing growth of around 18% year-on-year. The performance reflects
improving operating efficiency and continued demand for specialized
medical services.

Market significance: SMC’s performance demonstrates the
potential for specialized healthcare providers to generate attractive
earnings growth through higher-value medical services and improved
operational efficiency.

6. Fakeeh Care Faces Short-Term Earnings Pressure

Dr. Soliman Abdel Kader Fakeeh Hospital Company
(Fakeeh Care, Tadawul: 4017) reported first-half 2026 net profit
of approximately SAR 96.3 million.

Profitability declined compared with the previous year despite the
continued scale of the company’s healthcare operations.

Expansion costs, depreciation, financing expenses and the ramp-up of
newer facilities remain important factors when assessing the company’s
near-term earnings.

Market significance: Fakeeh Care illustrates the
challenge of converting healthcare expansion and investment into
immediate shareholder returns.

7. Almoosa Health Records Strong Revenue Expansion

Almoosa Health (Tadawul: 4018) reported its first-half
2026 financial results during August.

The company continued to demonstrate strong revenue expansion, while
profitability was affected by the costs associated with developing and
expanding its healthcare network.

Second-quarter net profit reached approximately
SAR 38.5 million, while revenue reached a record
quarterly level of approximately SAR 405.6 million.

Market significance: Almoosa provides an important
example of a listed healthcare company in an expansion phase, where
revenue growth may precede full normalization of margins.

8. Saudi German Health Reports Mixed H1 Results

Middle East Healthcare Company (Saudi German Health,
Tadawul: 4009) announced its first-half 2026 results on
11 August 2026.

H1 net profit reached approximately SAR 67.8 million.
Although cumulative profitability remained under pressure, second-quarter
profit increased significantly to approximately SAR 34.4 million.

Market significance: The improvement in quarterly
profitability may indicate improving operating performance during the
second half of the year, although investors will continue to monitor
margins and the utilization of the company’s healthcare assets.

9. AlDawaa Medical Services Faces Retail Profitability Pressure

AlDawaa Medical Services (Tadawul: 4163) reported
first-half 2026 results during August, with profitability and revenue
affected by pressure in its core retail pharmacy operations.

At the same time, distribution and logistics activities continued to
expand, reflecting the company’s strategy of developing revenue streams
beyond traditional pharmacy retail.

Market significance: The company’s performance
demonstrates the increasing importance of diversification, logistics and
healthcare-distribution capabilities within the Saudi listed healthcare
market.

10. Scientific & Medical Equipment House Wins New Healthcare Contract

Scientific & Medical Equipment House
(Tadawul: 4014) announced during August that it had received
notification of the award of a catering services project for Armed
Forces Hospitals in the Western Region.

The development highlights the growing role of listed healthcare-support
companies in Saudi Arabia, where opportunities extend beyond direct
hospital operations into outsourced healthcare services and facility
support.

Market significance: Healthcare-support and
outsourcing companies are becoming an increasingly relevant component of
the Saudi listed healthcare investment universe.

August 2026: What the Listed Healthcare Market Is Telling Investors

The August 2026 results provide a clear indication that the Saudi listed
healthcare market continues to benefit from structural demand growth.
However, the financial performance of individual companies is becoming
increasingly differentiated.

1. Revenue Growth Remains Resilient

Several listed healthcare operators continue to report revenue and
patient-volume growth. Mouwasat, Dallah, SMC Healthcare and Almoosa are
among the companies demonstrating continued expansion of their operating
businesses.

2. Profitability Is Becoming the Critical Differentiator

August results show an important distinction between
revenue growth and sustainable profitability.
Companies expanding aggressively may experience short-term pressure from
depreciation, financing costs, staffing expenses and new-facility
ramp-up.

3. Capacity Expansion Requires Capital Discipline

The performance of companies such as Almoosa, Fakeeh Care and Saudi
German Health demonstrates that expanding hospital capacity requires
significant investment before new assets reach mature utilization.

For investors, future performance will therefore depend increasingly on
occupancy, patient volumes, payer mix, average revenue per patient,
operating margins and return on invested capital.

4. Insurance Remains a Major Market Driver

Bupa Arabia’s performance reinforces the strategic importance of private
health insurance within the Saudi healthcare ecosystem. Increasing
insurance penetration and healthcare utilization continue to support
demand across the provider market.

5. The Listed Healthcare Universe Is Becoming More Diverse

Saudi Arabia’s listed healthcare market now extends well beyond
traditional hospitals. The listed universe includes medical insurance,
hospital operators, pharmacy chains, specialized healthcare providers,
medical equipment companies and healthcare-support services.

Investor Perspective

From an investment perspective, August 2026 suggests that the Saudi
healthcare sector remains fundamentally attractive, but the market is
becoming more selective.

The key question is increasingly not simply:
“Which companies are growing?”
but rather:
“Which companies can convert growth into sustainable cash flow,
margins and shareholder returns?”

Healthcare companies with strong utilization, disciplined capital
expenditure, sustainable margins and efficient balance sheets may be
better positioned to benefit from the continued expansion of Saudi
healthcare demand.

Key Takeaway

Saudi Arabia’s listed healthcare sector continues to expand, but
August 2026 results show that the market is entering a more
sophisticated phase in which revenue growth must increasingly be
converted into sustainable profitability, cash flow and shareholder
value.

Companies Covered

The August review covers the following Saudi-listed healthcare and
healthcare-related companies:

• Bupa Arabia — Tadawul: 8210
• Mouwasat Medical Services — Tadawul: 4002
• Al Hammadi Holding — Tadawul: 4007
• Dallah Healthcare — Tadawul: 4004
• SMC Healthcare — Tadawul: 4019
• Fakeeh Care — Tadawul: 4017
• Almoosa Health — Tadawul: 4018
• Saudi German Health — Tadawul: 4009
• AlDawaa Medical Services — Tadawul: 4163
• Scientific & Medical Equipment House — Tadawul: 4014